| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.036 | 0.6 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.037 | 0.6 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.6 |